Home/Filings/4/0001493152-24-052168
4//SEC Filing

Arno Andrew 4

Accession 0001493152-24-052168

CIK 0001642380other

Filed

Dec 25, 7:00 PM ET

Accepted

Dec 26, 6:17 PM ET

Size

7.3 KB

Accession

0001493152-24-052168

Insider Transaction Report

Form 4
Period: 2024-12-26
Arno Andrew
Director
Transactions
  • Purchase

    Common Stock, no par value

    2024-12-26$2.11/sh+12,500$26,35081,554 total
Holdings
  • Common Stock, no par value

    (indirect: See footnote)
    7,804
  • Common Stock, no par value

    (indirect: See footnote)
    7,804
Footnotes (3)
  • [F1]The price of $2.1080 per share represents a weighted average of prices ranging from $2.1000 to $2.1300 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]These shares of Common Stock are held by JBA Investments LLC ("JBA"). The Reporting Person is the Manager of JBA and, in such capacity, has the right to vote and dispose of securities held by JBA, including the shares of Common Stock reported here.
  • [F3]These shares of Common Stock are held by MJA Investments LLC ("MJA"). The Reporting Person is the Manager of MJA and, in such capacity, has the right to vote and dispose of securities held by MJA, including the shares of Common Stock reported here.

Documents

1 file

Issuer

Oncocyte Corp

CIK 0001642380

Entity typeother

Related Parties

1
  • filerCIK 0001472122

Filing Metadata

Form type
4
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 6:17 PM ET
Size
7.3 KB